Epidemiological studies suggest that intra-uterine exposure to inflammation may prime postnatal immune responses. In fetal sheep, intra-amniotic injection of lipopolysaccharide (LPS) induced chorioamnionitis, lung inflammation and maturation, matured lung monocytes to macrophages and initiated systemic tolerance of fetal monocytes to subsequent challenge with LPS. We hypothesized that LPS-mediated chorioamnionitis altered the response of lung and blood monocytes to Toll-like receptor (TLR) ligands such as PamCysK4 (TLR2), flagellin (TLR5), and human CpG-DNA (TLR9). Time-mated ewes were given intra-amniotic injections of LPS or saline. Blood and lung monocytes were assessed after 2 days, 7 days and 2 days and 7 days repetitive LPS injections before delivery at 124 days gestational age (term 150 days). Responsiveness of blood and lung monocytes to TLR-ligands in vitro was assessed by interleukin (IL)-6, tumor necrosis factor-a (TNF-a) and hydrogen peroxide. Monocytes from preterm controls had minimal responses. Lipopolysaccharide-mediated chorioamnionitis increased IL-6, TNF-a and hydrogen peroxide to all TLR agonists in blood and lung monocytes. Repetitive exposure to antenatal LPS reduced IL-6, TNF-a and hydrogen peroxide to TLR-ligands suggesting tolerance. Tolerance to TLR-ligands reduced IL-1 receptor associated kinase-4 expression. Thus, repeated fetal exposure to LPS induced tolerance to other TLR-ligands. These modulations of fetal innate immunity have implications for host defense and injury responses in preterm infants.
INTRODUCTION
Tolerance or preconditioning is the general phenomenon of decreased responses to a second exposure following a prior exposure to a sub-lethal insult. 1 The inflammatory nature of the prior exposure need not be the same as the challenge exposure. For example, sub-lethal exposure to LPS can protect the brain from a hypoxic insult. 1 In the context of innate immune responses, an initial exposure to a TLR4 agonist can induce protection from subsequent exposure to the same TLR4 agonist or to a TLR2 agonist, a phenomenon referred to as cross-tolerance. 2, 3 Systemic and organ-specific tolerance responses occurred in adult animals with fully competent immune systems. 4 The alterations in inflammation induced by tolerance have been identified in in vitro systems and transgenic mice. 5 The fetus is unique because the innate immune system is both naive and immature. [6] [7] [8] [9] [10] Nevertheless, the fetus may be exposed chronically to low pathogenic organisms that are associated with chronic chorioamnionitis, preterm labor and delivery. 11, 12 This chorioamnionitis is often clinically silent and is diagnosed by pathological examination of the placenta and membranes. 13 The human fetus also seems to be able to co-exist with these low pathogenic organisms without preterm labor. 14, 15 The innate immune adaptations of the fetus within the immune-suppressed environment of pregnancy have been minimally studied.
We have used intra-amniotic injections of proinflammatory mediators such as Escherichia coli LPS, IL-1, and live Ureaplasma urealyticum to model chorioamnionitis, the resultant lung inflammation, and subtle systemic inflammatory responses in fetal sheep. [16] [17] [18] [19] The immature blood monocytes that are unresponsive to the TLR4 agonist LPS become responsive 7 days and 14 days after intra-amniotic fetal LPS exposure. 20 Similarly, lung monocytes become responsive and differentiate to macrophages after intraamniotic LPS. 21 These responses are interpreted to be maturation of naive cells on initial exposure to the TLR4 agonist. In contrast, fetal blood monocytes and lung monocytes/macrophages from fetuses exposed to intraamniotic LPS both 2 days and 7 days prior to an in vitro challenge with LPS were unresponsive, indicating a superimposed LPS-tolerance type response. 20, 22 To explore immune programming further, we hypothesized that LPS-mediated chorioamnoitis would mature the response potentials of monocytes from cord blood and lung monocytes/macrophages to other TLR agonists ('cross-maturation'). We also hypothesized that cells from animals that were repetitively exposed in utero to the TLR4 ligand would be 'cross-tolerant' to other TLR agonists. Fetal cells were tested in vitro for responses to LPS (TLR4) agonist, flagellin (ligand for TLR5), PamCysK (ligand for TLR2), and human CpG-DNA (ligand for TLR9). Intracellular signaling by TLR was evaluated by measurements of cytosolic IRAK-kinases 4 and M.
MATERIALS AND METHODS

Animals
All animal experiments were carried out in Western Australia with the approval of the ethical committees of the Department of Agriculture, Western Australia, Australia, and the Children's Hospital Research Foundation, Cincinnati, OH, USA. Time-mated ewes with singletons were assigned to groups of 6 or 7 animals for ultrasound-guided intra-amniotic injections of LPS (10 mg, E. coli O55:B5; Sigma Chemicals, St Louis, MO, USA) or saline ( Fig. 1 ). All animals were delivered at the same gestational age of 124 days (term 150 days). Adult sheep were 2 years of age. Responses of bloodderived monocytes and lung-derived monocytes/ macrophages were assessed at 2 days, 7 days and 2 days and 7 days after the LPS injections. Each pregnant ewe was killed with a penetrating captive bolt with immediate operative delivery of the fetus. After cutting the umbilical cord, the lamb was given a lethal dose of pentobarbital, weighed and exsanguinated by cutting the abdominal aorta.
Cell isolation from cord blood and culture
Cord blood was collected from an umbilical artery after the delivery of each fetus. Blood from healthy adult ewes also was collected as the adult control (n ¼ 8). The blood was diluted with PBS and layered onto a Percoll gradient with a density of 1.09 g/l (Amersham Pharmacia Biotech, Piscataway, NJ, USA). 21 After centrifugation at 400 g at 20 C for 40 min, the mononuclear cells were recovered, washed twice with PBS at 4 C, centrifuged at 400 g and 4 C for 5 min and suspended in culture media (Dulbecco's modified minimal media [DMEM]) supplemented with 10% heat-inactivated fetal calf serum (Sigma). 8 Cells were counted using Trypan Blue to evaluate viability and the cells were plated on culture dishes. After incubation at 37 C for 30 min, nonadherent cells were removed and plates were washed twice with PBS. To estimate the number of monocytes, cells were scraped from the culture dishes, and differential cell counts were performed on cytospin preparations stained with Diff-Quick (Scientific Products, McGraw Park, IN, USA). The adherent cell population was 91 AE 5% monocytes for the treatment and control groups. Monocytes in other culture dishes were cultured overnight, and the experiments were done the following day after 16 h in culture.
Monocyte/macrophage isolation from lung tissue and culture
Monocytes and macrophages from fetal lung tissue were isolated as previously described. 21 In brief, following vascular perfusion of the right lower lobe with Hank's Balanced Salt Solution (HBSS), the lobe was chopped thoroughly with scissors into fine pieces. Enzymatic digestion was not performed to minimize contamination with lung cells. The minced lung was shaken in HBSS at 37 C for 1 h. The lung suspension was then passed through a 100 mm mesh filter and the resulting cell suspension was centrifuged twice to recover the cells. The cells were then layered onto a two-step Percoll gradient (1.085 g/ml and 1.046 g/ml) and centrifuged at 400 g and 4 C for 10 min. 21 Monocytic cells were recovered from the interface between the two Percoll densities and the cell concentration adjusted to 2.0 Â 10 6 cells/ml.
Alveolar macrophages were obtained from healthy adult ewes by bronchoalveolar lavage
Immediately after euthanasia, the trachea was isolated and a sterile tube was wedged into the bronchus. 22 Cold saline was instilled into the lung and removed by gravity; this procedure was repeated 3 times. Alveolar macrophages were recovered from the saline by centrifugation at 400 g at 4 C for 10 min, suspended in PBS, counted, washed and transferred into cell culture media at 2.0 Â 10 6 cells/ml.
Interleukin-6 and TNF-a concentrations
After overnight incubation of blood and lung monocytes in media, the cells were washed with PBS and new culture media was added. The cells were cultured for 6 h with LPS (100 ng/ml; E. coli O55:B5; Sigma), a dose which induces a robust response in preterm monocytes, 8 flagellin from Salmonella enterica sv. Muenchen (100 ng/ml; Calbiochem, La Jolla, CA, USA), PamCysK4, a synthetic ligand for TLRs 1 and 2 (5 mg/ml; EMC Microcollection, Tuebingen, Germany), and CpG-DNA, a synthetic ligand for TLR9 (25 mg/ml; InvivoGen, San Diego, CA, USA). 23 The monocytes were scraped from the culture dishes, counted and assessed for viability with Trypan Blue. Control cells were exposed to saline and were included in all experiments. Concentrations of IL-6 were determined in the supernatant of LPS-stimulated monocytes with an ovine-specific, enzyme-linked immunosorbent assay (ELISA) as previously described. 24 Tumor nekrosis factor-a concentrations were measured in cell culture supernatants with a commercial ovine-specific ELISA. 7 Supernatants from untreated cell samples cultured for the same period of time were used as controls.
Hydrogen peroxide production
After overnight incubation, monocytes were washed with PBS and new culture media was added. After 6-h incubation with Toll ligands, monocytes were scraped from the culture dish, counted and assessed for viability with Trypan Blue. Production of hydrogen peroxide by 1 Â 10 6 monocytes was measured with an assay based on the oxidation of ferrous iron (Fe 2þ ) to ferric iron (Fe 3þ ) by hydrogen peroxide under acidic conditions (Bioxytech H 2 O 2 -560 assay, OXIS International, Portland, OR, USA). Control samples were exposed to saline instead of endotoxin and were included in all experiments. 8 
IRAK-4 and IRAK-M
Cells were recovered after incubation. Cell pellets were dissolved in Laemmli's buffer for Western blot analysis. 22 After SDS-PAGE, proteins were transferred onto PVDF membranes as previously described. 22 Blots were probed with monoclonal antibodies against IRAK-4 and IRAK-M (Abcam, Cambridge, UK), respectively. After stripping the membranes, blots were probed with a monoclonal antibody against ovine b-actin as a standard for loading (Sigma). Intensity of staining was visualized with Vector stain and quantified on a BIORAD scan.
Statistical analysis
Results are given as mean AE SEM. Comparisons between the groups were done by ANOVA with Student-Newman test for post-hoc analysis. Significance was accepted at P < 0.05.
RESULTS
Decreased IL-6, TNF-a and hydrogen peroxide responses in preterms
Fetal blood and lung-derived monocytic cells secreted very little IL-6, Tumor nekrosis factor-a and hydrogen peroxide in response to LPS in vitro relative to blood monocytes or alveolar macrophages from adult sheep. This same lack of responsiveness occurred for the other TLR agonists for the cells from the preterm fetuses (Figs 2-4 ). Blood monocytes and alveolar macrophages from adult sheep secreted similar amounts of IL-6, TNF-a and hydrogen peroxide on stimulation with all the TLR-agonists, indicating that mature sheep cells respond to all agonists.
Intra-amniotic LPS-induced monocyte responses
Monocytes did not respond in culture to LPS 2 days after the intra-amniotic exposure. The 7 day LPS exposure in vivo strikingly increased the in vitro secretion of IL-6, TNF-a and hydrogen peroxide to challenge with the four other TLR-agonists (Figs 2-4 ). The responses of both blood monocytes and lung monocytic cells approached those for alveolar macrophages from adult sheep. Therefore, exposure of the fetus to one TLR-agonist induced or matured the monocytic cell response potential to other TLR-agonists in the fetus.
Cross-tolerance responses
An initial intra-amniotic injection of LPS followed 5 days later by a second intra-amniotic injection of LPS 2 days before in vitro challenge with the same TLR agonist decreased the secretion of IL-6, TNF-a and hydrogen peroxide (Figs 2-4) relative to the single 7 day exposure. The responses were similar for blood monocytes and lung tissue derived monocytic cells. The second LPS exposure in vivo also suppressed IL-6, TNF-a and hydrogen peroxide responses to the other TLR-agonists when the cells were challenged in vitro. Therefore, the prior two fetal exposures to LPS in vivo caused tolerance-type responses to not only LPS, but also a cross-tolerance to the other TLR-agonists.
IRAK-4 and IRAK-M
The changes in IRAK-4 and IRAK-M protein levels in the monocytes/macrophages from the fetal lungs and from alveolar macrophages from adult sheep were measured by Western blots. The 2 day fetal exposures did not alter IRAK-4 or IRAK-M levels following challenge with the TLR agonists in vitro (data not shown). In contrast, the 7 day fetal exposure increased IRAK-4 levels in the lung cells in response to in vitro challenge to all the TLR-agonists (Fig. 5) . In contrast, the 2 day plus 7 day exposures decreased IRAK-4 levels Fig. 3 . Concentrations of TNF-a in cell culture media relative to media control. The in vivo exposure groups are indicated on the Y-axis and the in vitro agonists are indicated by the base. 'LPS' is 10 mg intra-amniotic LPS at the indicated time before delivery. 'Adult' indicates alveolar macrophages from adult ewes. Blood monocytes (A) and lung-derived monocytes (B) from preterm animals exposed in utero to saline secreted little TNF-a on stimulation with the TLR agonists while cells from adult sheep secreted TNF-a. In vitro stimulation with the TLR agonists induced a robust increase in TNF-a in the cell culture media 7 days, but not 2 days, after intra-amniotic LPS (IA LPS). In contrast, blood and lung cells from animals exposed at 2 days and 7 days to intra-uterine LPS had decreased secretion of TNF in vitro in response to all TLRagonists (*P < 0.05 versus saline control, t P < 0.05 for 7 days versus 2 days þ 7 days endo). Interleukin-6 concentrations in cell culture media relative to media control. The in vivo exposure groups are indicated on the Y-axis and the in vitro agonists are indicated by the base. 'LPS' is 10 mg intraamniotic LPS at the indicated time before delivery. 'Adult' indicates alveolar macrophages from adult ewes. Blood monocytes (A) and lungderived monocytes (B) from preterm animals exposed in utero to saline did not secrete IL-6 on stimulation with the TLR agonists while cells from adult sheep secreted IL-6. In vitro stimulation with the TLR agonists induced a robust increase in IL-6 in the cell culture media 7 days, but not 2 days, after intra-amniotic LPS (IA LPS). In contrast, blood and lung cells from animals exposed at 2 days and 7 days to intrauterine LPS had decreased secretion of IL-6 in vitro in response to all TLR-agonists (*P < 0.05 versus control; t P < 0.05 for 7 days versus 2 days þ 7 days endo). below saline control values and increased IRAK-M levels relative to control and the single 7 day in vivo LPS exposure.
DISCUSSION
Chorioamnionitis or inflammation of the fetal membranes is a common association with prematurity affecting more than 60% of preterm infants born before 30 weeks' gestation. 11 We have used intraamniotic LPS to simulate chorioamnionitis in the preterm fetal sheep, which exposes the epithelia of the lungs, gastrointestinal tract, skin and the chorio-amnion to LPS but does not result in detectable LPS in the fetal blood. 22 Intra-amniotic LPS induces lung inflammation, a modest systemic inflammation and lung maturation but does not cause acidosis or adverse cardiovascular responses in fetal sheep. 16, 17 We previously published that intra-amniotic LPS induces tolerance both in vivo and in vitro to LPS in the preterm sheep fetus. 20, 22 We believe that this is the first description of in vivo LPS-induced cross-tolerance in the preterm fetus to TLR2, TLR4, TLR5 and TLR9 agonistic in vivo challenge.
The fetus is generally considered to be immunologically incompetent. Accordingly, blood monocytes or lung monocytes from the preterm sheep exposed to a single intra-amniotic injection of LPS 2 days prior to delivery did not respond to a panel of TLR agonists. We previously reported that exposure to intra-amniotic LPS on day 7 can induce preterm fetal monocytes to become competent to respond to an in vitro LPS challenge. 20, 22 This study demonstrates that monocytes from preterm fetal sheep exposed to intra-amniotic LPS also became competent to respond to the other TLR agonists. The intra-amniotic LPS-induced maturation phenomenon is broad and involves multiple TLR pathways. We also reported recently that lung monocytes from the preterm fetus precociously mature to macrophages after exposure to intra-amniotic LPS. 21 Thus, exposure to intra-amniotic LPS can induce maturation of monocyte function. Therefore, these results underscore the importance of interpreting the results of in vitro TLR agonist challenge in the context of two mutually distinct phenomena in the preterm fetus -maturation and tolerance after LPS exposure. Results are expressed as fold increase over controls. Cells from saline control animals had a modest increase in IRAK-4 protein (A) after stimulation with the TLR agonists for TLR4 (LPS) and CpG (TLR9) but did not reach statistical significance with the other TLR agonists. Cells isolated from fetuses exposed to 7-day LPS-induced chorioamnionitis had a further increase in IRAK-4 after stimulation with TLR agonists in comparison to cells from control animals. This increase was blunted in cells from animals exposed to intra-amniotic LPS injections 2 days and 7 days before in vitro challenge with the TLR agonist. The expression of IRAK-4 was reduced to about half of the responses for the saline control groups. Expression of IRAK-M was quantified in the same samples (B). No significant changes were seen after stimulation with TLR agonists in cells from saline control animals or for animals after 7 days of exposure to LPS-induced chorioamnionitis. However, the expression of IRAK-M was increased in cells from animals that have been previously exposed to repetitive LPS injections 2 days and 7 days before delivery (*P < 0.05 versus corresponding control). Fig. 4 . Hydrogen peroxide production of monocytes from blood (A) and lung monocytes (B). Blood monocytes (A) and lung-derived monocytes (B) from preterm animals were cultured overnight and exposed to a panel of TLR agonists. Hydrogen peroxide production was increased after stimulation in cells from blood and lung in animals exposed for 7 days to chorioamnionitis. Hydrogen peroxide production was lower in cells from blood and lung in animals exposed 2 days and 7 days before delivery to intra-amniotic endotoxin (*P < 0.05 versus saline control; t P < 0.05 for 7 days versus 2 days þ 7 days endo).
In vitro and in vivo studies in the adults have found LPS-induced tolerance. 25, 26 We previously reported both in vivo and in vitro endotoxin tolerance in preterm fetal sheep exposed to repeated injections of intra-amniotic LPS. 20, 22 On the other hand, cross-tolerance to other TLR agonists as a result of LPS challenge has been reported in some, but not in all, studies. Sato et al. 27 reported that pretreatment of peritoneal macrophages from adult mice with LPS did not induce cross tolerance to MALP-2, a TLR2/6 agonist. However, another study found that LPS induced cross-tolerance to TLR2 and TLR9 agonists in adult mice in vivo as well as in vitro. 4 Conditioning with LPS also induced tolerance and neuroprotection against hypoxia-ischemia-induced brain injury. 1 Thus exposure to LPS can induce different effects on signaling via different TLRs or other signaling pathways depending on the experimental conditions, cell types and perhaps doses used. Our study demonstrates that exposure to repeated intra-amniotic LPS injections induced cross-tolerance to TLR2, TLR5 and TLR9 signaling in lung and blood monocytes from the preterm fetus.
Cross-tolerance has also been reported after exposure to TLR agonists other than LPS. Monocytes, macrophages and dendritic cells became cross-tolerant to LPS following prior exposure to a TLR2 agonist. 3, 4, 28 In vivo, exposure to a TLR2 agonist, but not a TLR9 agonist, induced cross-tolerance to TLR2 and TLR4 agonists. 4 Tolerance following TLR agonist exposure results in multiple gene products being differentially activated. Sato et al. 29 reported that MALP-2, a TLR2 agonist, induced cross-tolerance for MyD88-dependent TLR4 signaling but not for MyD88-independent TLR4 signaling. We reported that intra-amniotic LPS induced interferon-inducible gene expression in the fetal sheep lung, a surrogate marker of MyD88-independent signaling. 30 Fetal sheep exposed repeatedly to intra-amniotic LPS developed tolerance and down-regulation of IL-1b expression but not the expression of the acute phase reactant SAA3 in the fetal lung. 22 Geisel et al. 28 reported that mature mouse dendritic cells developed crosstolerance between TLR2 and TLR4 agonists for TNF-a secretion but not IL-6 secretion. In this study, monocytes from fetal sheep exposed to repeated intra-amniotic LPS developed cross-tolerance to other TLR agonists for both TNF-a, IL-6 secretion and hydrogen peroxide production.
The mechanisms of tolerance to TLR signaling are not completely understood. Extracellular/humoral factors that potentially mediate tolerance to TLR signaling include steroid hormones, 31 HSP-70, 32 and IL-10. 33 Repeated exposure to intra-amniotic LPS did not change the very low plasma cortisol levels and lung expression of IL-10 mRNA remained low in fetal lambs, 22 suggesting other mechanisms of cross tolerance in these animals. Modulation of TLR receptor expression generally has not been a mechanism of cross-tolerance. 34 However, fetal sheep exposure to intra-amniotic LPS did not change expression of TLR4 by fetal monocytes 20, 22 and modestly increased TLR2 and TLR4 mRNA in the fetal lung. 10 The family of IRAK signal transducing molecules acting downstream of MyD88 modulate multiple TLR signaling, with IRAK-4 being a positive regulator and IRAK-M a negative regulator. 35, 36 In this study, the tolerant fetal lung and blood monocytes had decreased IRAK-4 levels and increased IRAK-M expression, suggesting a post-receptor mechanism of altered TLR signaling. A growing list of other intracellular mediators including MyD88s, 37 SIGIRR, 38 SOCS-1, 39 and others have been proposed as mediators of endotoxin tolerance. The precise molecular pathways to TLR cross-tolerance in the fetus remain to be identified.
There is a growing body of evidence from epidemiological studies that a majority of very preterm fetuses are exposed to infectious organisms, often chronically. 14, 15 However, the clinical impression is that these preterm infants at birth have minimal inflammatory manifestations. It is not known if these preterm infants develop tolerance or cross-tolerance to TLR signaling. Tolerance responses may limit inflammation-induced lung and systemic injury in these fetuses. Indeed, we reported that preterm lamb fetuses exposed to a single injection of intra-amniotic LPS had lung remodeling similar to bronchopulmonary dysplasia, but exposure to repeated intra-amniotic LPS did not result in progressive lung remodeling. 40 On the other hand, endotoxin tolerance may inhibit host responses to invading pathogens. Endotoxin tolerance increases the risk of infections and mortality and thus is maladaptive in the intensive care setting. 41 About 25% of very low birth weight preterm neonates develop postnatal nosocomial sepsis 42 and exposure to chorioamnionitis might increase the susceptibility of preterm infant to nosocomial sepsis.
